
Last update at 2026-01-30 15:53:22
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Income before tax | 448.01M | 607.68M | 1087.20M | 1349.89M | 924.34M |
| Net income | 297.70M | 426.40M | 807.14M | 1006.64M | 688.70M |
| Total Revenue | 3924.14M | 2963.94M | 2832.48M | 2991.90M | 2279.09M |
| Gross Profit | 1350.92M | 985.42M | 2181.94M | 2191.26M | 1536.29M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Total assets | 10800.40M | 9721.84M | 7256.83M | 5442.26M | 2959.50M |
| Intangible assets | 317.42M | 366.03M | 5.12M | 6.64M | 5.83M |
| Other current assets | 112.69M | 9.29M | 118.50M | 110.96M | 637.73M |
| Deferred long term liab | - | - | - | - | - |
| Non current assets other | - | - | - | - | - |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Change in Cash | 85.42M | -419.48M | -183.84M | 751.10M | -229.79M |
| Operating Cash | 966.20M | 1027.05M | 755.99M | 834.67M | 681.55M |
| Free Cash Flow | -550.87M | -816.28M | -1143.69M | -485.02M | 38.33M |
Sector: Healthcare Industry: Medical Instruments & Supplies
| Company | Change | Price | Market Cap (M) | P/E Ratio |
|---|---|---|---|---|
| TARSONS Tarsons Products Limited |
-1.06 -0.54% | 194.10 | 11941.79 | 57.98 |
| POLYMED Poly Medicure Limited |
-116.50 -7.75% | 1386.00 | 180105.67 | 49.83 |
| AGARWALEYE AGARWALEYE |
-6.45 -1.41% | 450.00 | 106150.05 | 453.72 |
| LAXMIDENTL LAXMIDENTL |
-4.29 -2.07% | 203.28 | - |
Tarsons Products Limited manufactures and trades in scientific plastic labware products in India and internationally. The company offers bottles and carboys; boxes and racks; cell cell culture ware, centrifuge ware, clamps and stands, cryoware, desiccator, tubings and connectors, filtration, genomics and PCR consumables, laboratory equipment and utilities, liquid handling consumables and reusables, magnetic stirrer bar, pp storage plates, sampling aids, vials and tubes, and volumetric reusables. It also provides general lab ware products. Its products are used in molecular biology, cell culture, genomics, proteomics, and immunology. Tarsons Products Limited was incorporated in 1983 and is headquartered in Kolkata, India.
Martin Burn Business Park, Kolkata, India, 700091
| Name | Title | Year Born |
|---|---|---|
| Mr. Sanjive Sehgal | Chairman, CEO & MD | 1961 |
| Mr. Santosh Kumar Agarwal | CFO, Company Sec. & Compliance Officer | NA |
| Mr. Rohan Sehgal | Whole-time Director | 1988 |
| Keshavmurthy Annantrao Kabboor | Chief Operating Officer | NA |
| Mr. Santosh Kumar Agarwal | CFO, Company Secretary & Compliance Officer | NA |
| Mr. Aryan Sehgal | Whole-time Director | 1988 |
| Mr. Lakshmananarayanan Balakrishna Reddy | Vice President of Operations | NA |
| Mr. Subhra Sankar Bose | Head of Human Resource | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.